|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
32
|
|
pubmed:dateCreated |
1999-11-30
|
|
pubmed:abstractText |
BCG therapy is an effective treatment for superficial bladder carcinoma. Exceptionally, systemic disorders including hypersensitivity reactions or infections may occur.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0755-4982
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
23
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1753-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
[Sepsis syndrome and bone marrow granulomatosis after intravesical instillation of BCG].
|
|
pubmed:affiliation |
Services de Médecine Interne et Nutrition, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
